Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon Jan

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Virology Journal|February 28, 2025
Lassa virus protein-protein interactions as mediators of Lassa fever pathogenesisSharon Jan, Kruttika S Phadke, Victor L Lam, et al.
Pathogens (Basel, Switzerland)|May 4, 2026
Hemorrhagic Fever Disease in STAT-1 Knockout Mice Infected with Lujo VirusDylan M Johnson, Sharon Jan, Ethan Dunn, et al.
Biomacromolecules|November 17, 2021
Multifunctional Dendronized Polypeptides for Controlled AdjuvanticityZhiyuan Fan, Sharon Jan, James C Hickey, et al.
Frontiers in Immunology|June 6, 2022
Multimericity Amplifies the Synergy of BCR and TLR4 for B Cell Activation and Antibody Class SwitchingEgest J Pone, Jenny E Hernandez-Davies, Sharon Jan, et al.
Journal of Materials Chemistry. B|June 14, 2024
Administration sequence- and formation-dependent vaccination using acid-degradable polymeric nanoparticles with high antigen encapsulation capabilityYeon Su Choi, Jiin Felgner, Sharon Jan, et al.
Frontiers in Cellular and Infection Microbiology|April 5, 2021
Auranofin Resistance in <i>Toxoplasma gondii</i> Decreases the Accumulation of Reactive Oxygen Species but Does Not Target Parasite Thioredoxin ReductaseChristopher I Ma, James A Tirtorahardjo, Sharon Jan, et al.
Antiviral Research|March 8, 2024
Broad antibody and T cell responses to Ebola, Sudan, and Bundibugyo ebolaviruses using mono- and multi-valent adjuvanted glycoprotein vaccinesJiin Felgner, Elizabeth Clarke, Jenny E Hernandez-Davies, et al.
Frontiers in Immunology|August 2, 2021
Administration of Multivalent Influenza Virus Recombinant Hemagglutinin Vaccine in Combination-Adjuvant Elicits Broad Reactivity Beyond the Vaccine ComponentsJenny E Hernandez-Davies, Jiin Felgner, Shirin Strohmeier, et al.
Frontiers in Immunology|August 3, 2023
Multivalent vaccines demonstrate immunogenicity and protect against <i>Coxiella burnetii</i> aerosol challengeSharon Jan, Alycia P Fratzke, Jiin Felgner, et al.
Bioconjugate Chemistry|September 8, 2023
Engineering Protein Nanoparticles Functionalized with an Immunodominant <i>Coxiella burnetii</i> Antigen to Generate a Q Fever VaccineAaron Ramirez, Jiin Felgner, Aarti Jain, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Virology Journal|February 28, 2025
Lassa virus protein-protein interactions as mediators of Lassa fever pathogenesisSharon Jan, Kruttika S Phadke, Victor L Lam, et al.
Pathogens (Basel, Switzerland)|May 4, 2026
Hemorrhagic Fever Disease in STAT-1 Knockout Mice Infected with Lujo VirusDylan M Johnson, Sharon Jan, Ethan Dunn, et al.
Biomacromolecules|November 17, 2021
Multifunctional Dendronized Polypeptides for Controlled AdjuvanticityZhiyuan Fan, Sharon Jan, James C Hickey, et al.
Frontiers in Immunology|June 6, 2022
Multimericity Amplifies the Synergy of BCR and TLR4 for B Cell Activation and Antibody Class SwitchingEgest J Pone, Jenny E Hernandez-Davies, Sharon Jan, et al.
Journal of Materials Chemistry. B|June 14, 2024
Administration sequence- and formation-dependent vaccination using acid-degradable polymeric nanoparticles with high antigen encapsulation capabilityYeon Su Choi, Jiin Felgner, Sharon Jan, et al.
Frontiers in Cellular and Infection Microbiology|April 5, 2021
Auranofin Resistance in <i>Toxoplasma gondii</i> Decreases the Accumulation of Reactive Oxygen Species but Does Not Target Parasite Thioredoxin ReductaseChristopher I Ma, James A Tirtorahardjo, Sharon Jan, et al.
Antiviral Research|March 8, 2024
Broad antibody and T cell responses to Ebola, Sudan, and Bundibugyo ebolaviruses using mono- and multi-valent adjuvanted glycoprotein vaccinesJiin Felgner, Elizabeth Clarke, Jenny E Hernandez-Davies, et al.
Frontiers in Immunology|August 2, 2021
Administration of Multivalent Influenza Virus Recombinant Hemagglutinin Vaccine in Combination-Adjuvant Elicits Broad Reactivity Beyond the Vaccine ComponentsJenny E Hernandez-Davies, Jiin Felgner, Shirin Strohmeier, et al.
Frontiers in Immunology|August 3, 2023
Multivalent vaccines demonstrate immunogenicity and protect against <i>Coxiella burnetii</i> aerosol challengeSharon Jan, Alycia P Fratzke, Jiin Felgner, et al.
Bioconjugate Chemistry|September 8, 2023
Engineering Protein Nanoparticles Functionalized with an Immunodominant <i>Coxiella burnetii</i> Antigen to Generate a Q Fever VaccineAaron Ramirez, Jiin Felgner, Aarti Jain, et al.
Pageof 2